ash impact series: paul richardson, md - examining the new fda approved myeloma drug products
Published 8 years ago • 354 plays • Length 6:17
Download video MP4
Download video MP3
Similar videos
-
6:35
ash impact series: vincent rajkumar, md - examining the new fda approved myeloma drug products
-
37:46
current and future directions for novel therapy for multiple myeloma: paul g. richardson, md
-
3:10
ash impact series: sagar lonial, md - examining multiple myeloma drug combination treatments
-
7:32
myeloma determination study | paul richardson, md | ims 2022
-
1:04:18
multiple myeloma mid-year progress with dr. paul richardson of dana farber
-
35:50
dr. paul richardson on novel approaches for treating multiple myeloma | dana-farber cancer institute
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
5:59
what is hrmm (high-risk multiple myeloma)?
-
7:19
renal insufficiency in multiple myeloma | ravi vij, md, mba | ims 2022
-
8:06
mezigdomide (cc-92480) | paul richardson, md | ash 2022
-
1:01:20
myeloma crowd radio: paul richardson, md, dana farber cancer institute
-
1:08:15
healthtree podcast for multiple myeloma: paul richardson, md, dana farber
-
1:28:28
mpatient myeloma radio: dr. paul richardson, md, dana-farber cancer institute
-
3:57
ash impact series: sagar lonial, md - treating newly diagnosed multiple myeloma
-
1:28:01
myeloma crowd: paul richardson, md, dana farber cancer institute
-
5:03
paul richardson: isatuximab improves pfs in relapsed/refractory myeloma
-
7:26
using imids and pis to treat at first relapse | paul richardson, md | ims 2023
-
5:04
ash 2014: prof paul richardson discusses relapsed/refractory myeloma
-
1:51
celmods® mezigdomide | paul richardson, md | ims 2022
-
1:59
sarclisa® (isatuximab) update | paul richardson, md | ims 2022
-
1:23
standards of care for myeloma patients | ash 2020
Clip.africa.com - Privacy-policy